Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Yilihua: It is recommended to allocate 50% of future returns to the AI sector

Yilihua: It is recommended to allocate 50% of future returns to the AI sector

AiCoinAiCoin2026/05/16 09:23
Show original
Liquid Capital founder Yilihua posted on X, stating that the current market rebound has basically ended and recommends an upward liquidation strategy. He mentioned possible negative factors including a correction in US stocks at high levels, the impact of oil prices on inflation, and a rebound in US Treasury yields. He believes the crypto market has long-term potential and that this is the darkness before dawn, emphasizing that a deep bear market offers a good opportunity to enter and exercise patience. In addition, he suggests allocating 50% of future returns to the AI sector, considering AI to be an irreversible trend.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD

Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.

智通财经2026/09/21 07:16

Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.

U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).

智通财经2026/09/21 07:11

Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential

According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.

智通财经2026/09/21 07:11

Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.

TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).

智通财经2026/09/21 07:11